Nationwide Fund Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Nationwide Fund Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,889	Closed	-$135K	–	449
2017 Q3	$135K	Hold	12,889	–	–	﹤0.01%	2786
2017 Q2	$161K	Buy	12,889 +2,802	+28%	+$27.7K	﹤0.01%	2722
2017 Q1	$101K	Buy	10,087 +1,422	+16%	+$21.1K	﹤0.01%	2840
2016 Q4	$135K	Hold	8,665	–	–	﹤0.01%	2767
2016 Q3	$167K	Hold	8,665	–	–	﹤0.01%	2709
2016 Q2	$103K	Buy	8,665 +3,665	+73%	+$60.5K	﹤0.01%	2904
2016 Q1	$91K	Buy	5,000 +731	+17%	+$13.3K	﹤0.01%	2859
2015 Q4	$117K	Hold	4,269	–	–	﹤0.01%	2789
2015 Q3	$94K	Hold	4,269	–	–	﹤0.01%	2911
2015 Q2	$76K	Buy	+4,269	New	+$73.8K	﹤0.01%	3062

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nationwide Fund Advisors's COLL Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Collegium Pharmaceutical (COLL) in Q4 2017, closing a stake of 12,889 shares — an estimated $135K sold.

Nationwide Fund Advisors first reported a position in COLL in Q2 2015 and held it in 10 quarters. The position peaked at $167K in Q3 2016. 101 funds tracked by Wall St. Rank hold COLL as of Q4 2017.

Nationwide Fund Advisors reported no remaining Collegium Pharmaceutical position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 12,889 Collegium Pharmaceutical shares in Q4 2017, an estimated $135K.
Nationwide Fund Advisors first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 10 quarters.
Nationwide Fund Advisors's Collegium Pharmaceutical position peaked at $167K in Q3 2016.
101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.